Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.40229 | 15 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.37032 | 15 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.37394 | 15 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.31201 | 15 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.31057 | 14 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.39533 | 14 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.37393 | 14 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.35083 | 15 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.34858 | 15 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.35968 | 15 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.35652 | 15 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.34436 | 15 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.36062 | 15 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.36127 | 15 |